|
Xiuling Li, Ph.D., was a research associate at The Scripps Research Institute. She earned her Ph.D. degree in pharmaceutical sciences, cancer biology from the University of Kentucky in 2012. Dr. Li is a Director at AstraZeneca with a focus on multispecific antibody engineering.
|
